Effects of vasopressin V1b receptor deficiency on adrenocorticotropin release from anterior pituitary cells in response to oxytocin stimulation

Endocrinology. 2008 Oct;149(10):4883-91. doi: 10.1210/en.2007-1528. Epub 2008 Jun 26.

Abstract

Oxytocin (OT) is one of the secretagogues for stress-induced ACTH release. OT-induced ACTH release is reported to be mediated by the vasopressin V1b receptor in the rat pituitary gland, which contains both OT and V1b receptors. We examined OT-induced ACTH release using primary cultures of anterior pituitary cells from wild-type (V1bR+/+) and V1b receptor knockout (V1bR-/-) mice. OT stimulated similar levels of ACTH release from pituitary cells of V1bR+/+ and V1bR-/- mice. OT-induced ACTH release was significantly inhibited by the selective V1b receptor antagonist SSR149415 and the OT receptor antagonist CL-14-26 in V1bR+/+ mice. In addition, cotreatment with SSR149415 at 10(-6) m and CL-14-26 at 10(-6) m inhibited OT-induced ACTH release to the control level inV1bR+/+ mice. In V1bR-/- mice, OT-induced ACTH release was significantly inhibited by CL-14-26 at 10(-8) m and completely inhibited at 10(-7)m. These results indicate that OT induces the ACTH response via OT and V1b receptors inV1bR+/+ mice but via only OT receptors in V1bR-/- mice. The gene expression level of the OT receptor was significantly higher in the anterior pituitary gland of V1bR-/- mice than in that of V1bR+/+ mice, suggesting that the OT receptor is up-regulated to compensate for ACTH release under conditions of V1b receptor deficiency.

MeSH terms

  • Adrenocorticotropic Hormone / metabolism*
  • Animals
  • Cells, Cultured
  • Gene Expression / drug effects
  • Gene Expression / physiology
  • Indoles / pharmacology
  • Male
  • Mice
  • Mice, Knockout
  • Oxytocin / metabolism
  • Oxytocin / pharmacology*
  • Pituitary Gland, Anterior / cytology
  • Pituitary Gland, Anterior / drug effects
  • Pituitary Gland, Anterior / physiology*
  • Pyrrolidines / pharmacology
  • RNA, Messenger / metabolism
  • Receptors, Oxytocin / genetics
  • Receptors, Oxytocin / metabolism
  • Receptors, Vasopressin / deficiency
  • Receptors, Vasopressin / genetics*
  • Receptors, Vasopressin / metabolism*
  • Reverse Transcriptase Polymerase Chain Reaction
  • Up-Regulation / drug effects
  • Up-Regulation / physiology

Substances

  • 1-(5-chloro-1-((2,4-dimethoxyphenyl)sulfonyl)-3-(2-methoxyphenyl)-2-oxo-2,3-dihydro-1H-indol-3-yl)-4-hydroxy-N,N-dimethyl-2-pyrrolidinecarboxamide
  • Indoles
  • Pyrrolidines
  • RNA, Messenger
  • Receptors, Oxytocin
  • Receptors, Vasopressin
  • Oxytocin
  • Adrenocorticotropic Hormone